ClinicalTrials.gg
CompletedNCT04143243Updated Oct 8, 2025Results posted

One-day Life Skills Workshop for Veterans With TBI, Pain, and Psychopathology: Evaluating Efficacy and Mechanism of Change

An interventional study of ACT on Life and Education, Resources, and Support in Traumatic Brain Injury, Chronic Pain and Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-08.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
176
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Mild traumatic brain injury (mTBI) is the signature wound of Veterans returning from the operations in Iraq and Afghanistan (i.e., OIF/OEF/OND), with up to 20 percent experiencing persistent post-concussive symptoms. Among Veterans with mTBI, the majority also experience stress-based psychopathology (e.g., depression, post-traumatic stress disorder, and/or generalized anxiety disorder) and chronic pain. To cope with distress, pain, and other difficulties, Veterans often turn to maladaptive avoidant coping strategies which offer short term relief but exacerbate/maintain mental health problems and have detrimental long-term effects on social, occupational, and community reintegration. Unfortunately, Veterans face important barriers to seeking mental health treatment, including stigma and logistical issues. This proposal aims to examine 1) the impact of a Veteran-centered, non-stigmatizing, 1-day "life skills group workshop" on overall distress and reintegration; and 2) the mechanisms by which this treatment might work as well as possible influences on treatment efficacy.

Read the detailed description

Traumatic brain injury (TBI) is the signature wound of Veterans returning from Operations Iraqi Freedom, Operation Enduring Freedom and Operation New Dawn (OIF/OEF/OND), with up to 20 percent exposed to a mild TBI (mTBI) and experiencing persistent post-concussive symptoms. Among those with a mTBI diagnosis, the majority also suffers from stress-based psychopathology (e.g., depression, post-traumatic stress disorder, generalized anxiety disorder), as well as chronic pain. To cope with distress, pain, and other difficulties, Veterans often turn to maladaptive avoidant coping strategies which offer short term relief but exacerbate/maintain mental health problems and have detrimental long-term effects on social, occupational, and community reintegration. Unfortunately, Veterans face significant barriers to engaging in mental health treatment, including stigma, the belief that one should overcome psychological difficulties on his/her own, and concern that receiving such care would negatively impact their careers. Practical barriers, including time constraints, distance from a treatment facility, and competing priorities (e.g., work and family demands), are also barriers to care. Even among Veterans who start mental health treatment, only a small minority complete a recommended course of evidence-based therapy.

Acceptance and Commitment Therapy (ACT) is a trans-diagnostic treatment model that helps patients to overcome avoidance by promoting acceptance-based coping and engagement in meaningful life activities. In this context, Veterans are asked to think about their "new mission(s)" after leaving the military and the importance of engaging in actions that fulfill their mission even when it may be difficult. ACT has established efficacy in the treatment of depression, anxiety, and chronic pain, and has been effectively implemented in various treatment-delivery formats, including 1-day group workshops. A 1-day ACT workshop addresses specific needs of Veterans with mTBI, stress-based psychopathology, and chronic pain (polytrauma triad) and important barriers to treatment. It 1) is trans-diagnostic (i.e., applies to more than one condition); 2) targets avoidance-based coping; 3) cultivates acceptance-based coping and builds on Veteran's values and goals to motivate them to make difficult decisions; 4) is delivered efficiently and thus more accessible; 5) is less stigmatizing and thus acceptable; and 6) address problems with treatment adherence and completion.

With the support of an RR\&D SPiRE pilot grant, the PIs developed a 1-day 'ACT on Life' workshop tailored specifically for the needs of Veterans with mTBI, stress-based psychopathology, and chronic pain. Veterans with this polytrauma were then randomly assigned to the 'ACT on Life' workshop (N=20) or to Treatment as Usual (TAU; N=12). All Veterans attending the 1-day ACT workshop completed it, and relative to TAU, exhibited greater improvements in distress and reintegration at the 3-month follow-up (effect sizes .68 and .47, respectively). Building on these promising preliminary findings, the investigators now propose to conduct a more rigorous randomized controlled trial with 212 Veterans to compare the efficacy of the 1-day ACT workshop to an active treatment comparison (Education, Resources, and Support; ERS) on symptoms of distress and social, occupational, and community reintegration. The investigators will also examine mediators and moderators of treatment response to identify which ACT components are directly responsible for treatment effectiveness and whether treatment benefits are constrained by various personal factors.

Establishing the efficacy of a 1-day ACT workshop for OEF/OEF/OND Veterans with mTBI and multiple coexistent conditions addresses key priorities of VHA RR\&D: 1. developing interventions which will improve the psychological health status of Veterans who have specific needs; and 2. enhancing the community, social, and occupational reintegration and functioning of post-deployment Veterans so that they may function more fully in society.

02

Conditions studied

  • Traumatic Brain Injury
  • Chronic Pain
  • Post Traumatic Stress Disorder
  • Depression
  • Anxiety

Keywords

  • Acceptance and Commitment Therapy
  • Veterans
  • polytrauma
  • traumatic brain injury
  • chronic pain
  • Post Traumatic Stress Disorder
  • depression
  • Anxiety
03

In context

Brain Injuries, Traumatic

1,721 studies on the registry are indexed under Brain Injuries, Traumatic; 447 are open to participants now.

This study's enrollment of 176 is above the median of 52 across 1,088 interventional studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,771 studies on the registry; 392 are open to participants now.

Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • OIF/OEF/OND Veteran
  • Stress-based psychopathology, as operationalized by a diagnosis of major depressive disorder, generalized anxiety disorder, or PTSD on the M.I.N.I. International Neuropsychiatric interview (M.I.N.I.)
  • Deployment-related mild TBI according to the definition of VA/DOD Clinical Practice Guidelines and determined by interview on the Boston Assessment of TBI-Lifetime (BAT-L)
  • Pain intensity and level of interference reported to be 5 (moderate) on the Defense and Veterans Pain Rating Scale (DVPRS)

Exclusion criteria

Exclusion Criteria:

  • History of bipolar disorder or primary psychotic disorder (e.g., schizophrenia, schizoaffective disorder) on the M.I.N.I.
  • A current diagnosis of severe substance use disorder on the M.I.N.I.
  • Moderate to severe suicide risk on the suicidality scale on the M.I.N.I.
  • History of neurological illness not related to TBI (self-reported and confirmed by Dr. Jorge)
  • Severe medical illness (e.g. liver failure, severe coronary artery disease and /or heart failure) posing a new and significant stress burden and requiring intensive treatment (self-reported and confirmed by Dr. Jorge)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
176 participants (actual)

Study arms

  • Active comparator
    ACT on Life

    Acceptance and Commitment Therapy plus Education, Resources and Support ('ACT on Life'). The ACT+ERS intervention will include: 1) Acceptance and Mindfulness Training (2-3 hours); 2) Committed Action Training (2-3 hours) involving helping Veterans clarify what matters most to them and what they want to stand for in life, how they want to behave, and what sorts of strengths and qualities they want to develop; and; 3) Education, Resources, and Support (1 hour).

    Behavioral: ACT on Life

  • Placebo comparator
    Education, Resources, and Support

    Information provided in the ERS workshop was compiled from existing VHA and community resources. Veterans will be educated about 1) symptoms of depression, anxiety and PTSD and how these conditions do and do not impact daily life and functional ability; 2) common difficulties and challenges with reintegration into civilian life; 3) mild TBI, differences between civilian and Veteran TBIs, shared/crossover symptoms (for example, memory and concentration difficulties, sleep disturbance, irritability can be symptoms of depression, PTSD, and mild TBI); 4) chronic pain; how it is often often misinterpreted as on-going damage, leading to fear of physical activities and resulting in increased sedentary behavior and declines in physical functioning; and 5) treatment options and resources. Basic resource counseling will include guidance on the evidence-based treatments available at VHA. Problem solving, relaxation, and deep breathing techniques will be covered

    Behavioral: Education, Resources, and Support

Interventions

  • BehavioralACT on Life

    1 day group workshop of ACT plus ERS

    Also known as: ACT plus ERS

  • BehavioralEducation, Resources, and Support

    1 day group workshop of Education, Resources, and Support

    Also known as: ERS

06

What researchers measure

Primary outcomes

  1. The Depression Anxiety and Stress Scale (DASS-21) -TOTAL Score

    The Depression Anxiety and Stress Scale (DASS-21) measure consists of 21 items that measure current symptoms of depression, anxiety, and stress with a total score. It has been used extensively in clinical trials, including those with military populations. Participants are asked to rate the extent to which they have experienced each state over the past week with a 4-point scale (from 0 = did not apply to me at all to 3 = applied to me very much). For total score, scores are summed and range from 0 to 63. Higher total scores indicate more severe symptoms of depression, anxiety and stress.

    Time frame: Through study completion, an average of 6 months following workshop/intervention attendance.

  2. Military to Civilian Questionnaire (M2C-Q)

    The Military to Civilian Questionnaire (M2CQ) is a 16-item self-report measure used to assess the difficulty veterans experience during the post-deployment reintegration process. A total score is calculated by dividing the sum of the item scores by the number of items the veteran completed (excluding those marked "Does not apply").The Minimum possible score is 0 (if all items are answered as "no difficulty" or "does not apply"). Maximum possible score is 4 (if all items are answered as "extreme difficulty"). Higher scores on the M2CQ indicate greater difficulty with reintegration into civilian life.

    Time frame: Through study completion, an average of 6 months following workshop/intervention attendance.

Secondary outcomes

  1. The PTSD Checklist for DSM-5 (PCL-5)

    The PCL-5 is a 20-item self-report questionnaire to assess post-traumatic stress disorder (PTSD) based on criteria of the Diagnostic and Statistical Manual for Mental Disorders - Version 5 (DSM-5). This scale is available from the National Center for PTSD and is extensively used in Veteran populations. Each item is rated on a 5-point scale with anchors from "not at all" to "extremely" indicating how much the participant has been bothered by the PTSD symptoms in the past month. A total symptom severity score can be obtained by summing the scores for a range of scores from 0 to 80. A higher total score demonstrates more severe PTSD symptoms.

    Time frame: Through study completion, an average of 6 months following workshop/intervention attendance.

  2. Defense and Veterans Pain Rating Scale (Pain Severity)

    The Defense and Veterans Pain Rating Scale (DVPRS) is a pain assessment tool that assesses severity of pain. It uses a numerical scale ranging from 0 to 10 to assess pain intensity. Minimum Score: 0, representing "No pain". Maximum Score: 10, representing "As bad as pain can be, nothing else matters". It is a reliable and valid instrument developed for use in military populations.

    Time frame: Through study completion, an average of 6 months following workshop/intervention attendance.

Other outcomes

  1. Acceptance and Action Questionnaire-II

    The Acceptance and Action Questionnaire-II (AAQ-II) is an ACT-specific self-report measure of psychological inflexibility. The AAQ was designed to measure mechanisms hypothesized to be at work in ACT treatments and has been found to mediate behavioral outcomes in ACT interventions. Seven items are rated on a 7-point scale, ranging from 1 ("never true") to 7 ("always true"), with higher scores reflecting greater levels of psychological inflexibility. The total score is calculated by summing the ratings for each of the seven items. The minimum possible score is 7 (7 items x 1 point each).The maximum possible score is 49 (7 items x 7 points each). Higher total scores indicate greater levels of psychological inflexibility and experiential avoidance.

    Time frame: Through study completion, an average of 6 months following workshop/intervention attendance.

  2. Valued Living Questionnaire (VLQ) - Success

    Valued Living Questionnaire (VLQ) is a self-report measure that assesses engagement in valued areas of life. Participants first rate the importance of 10 life domains (e.g., family, work, friends etc.) on a 10-point Likert scale (1 = not at all important to 10 = extremely important). They then rate the degree to which their actions over the past week were consistent with each value, from 1 (not at all consistent) to 10 (extremely consistent). The "success" score is the VLQ Composite Score and refers to the composite score that measures how consistently a person is living in accordance with their stated personal values. The Valued Living composite is calculated by multiplying the Importance and Consistency responses for each domain and then calculating the mean of those scores. The resulting Valued Living Composite scores can range from 10-100. A higher score indicates greater alignment between actions and values, which is associated with positive psychological outcomes.

    Time frame: Through study completion, an average of 6 months following workshop/intervention attendance.

  3. Self-reported Service Utilization (Emotional Problems)

    The outcome measure is either Yes or No and then we computed the percentage of study participants that responded 'yes' on having utilized services for emotional problems from any of the following, medical provider, spiritual provider(priest/minister), psychiatric help or had hospital admission(in or outpatient) or ER admission.

    Time frame: Through study completion, an average of 6 months following workshop/intervention attendance.

07

Results

Posted Oct 8, 2025

Participant flow

OIF/OEF/OND Veterans with deployment-related mTBI, stress-based psychopathology, and pain (polytrauma clinical triad) were recruited from VAMC, outpatient clinics and Veteran Community Organizations.

Participant flow — Overall Study
MilestoneACT on LifeEducation, Resources, and Support
Started9086
Completed8377
Not completed79

Outcome measures

PrimaryThe Depression Anxiety and Stress Scale (DASS-21) -TOTAL Score

The Depression Anxiety and Stress Scale (DASS-21) measure consists of 21 items that measure current symptoms of depression, anxiety, and stress with a total score. It has been used extensively in clinical trials, including those with military populations. Participants are asked to rate the extent to which they have experienced each state over the past week with a 4-point scale (from 0 = did not apply to me at all to 3 = applied to me very much). For total score, scores are summed and range from 0 to 63. Higher total scores indicate more severe symptoms of depression, anxiety and stress.

Time frame:
Through study completion, an average of 6 months following workshop/intervention attendance.
Reported as:
Mean · units on a scale
The Depression Anxiety and Stress Scale (DASS-21) -TOTAL Score
units on a scaleACT on LifeEducation, Resources, and Support
The Depression Anxiety and Stress Scale (DASS-21) -TOTAL Score28.97 ± 1.3430.77 ± 1.38
PrimaryMilitary to Civilian Questionnaire (M2C-Q)

The Military to Civilian Questionnaire (M2CQ) is a 16-item self-report measure used to assess the difficulty veterans experience during the post-deployment reintegration process. A total score is calculated by dividing the sum of the item scores by the number of items the veteran completed (excluding those marked "Does not apply").The Minimum possible score is 0 (if all items are answered as "no difficulty" or "does not apply"). Maximum possible score is 4 (if all items are answered as "extreme difficulty"). Higher scores on the M2CQ indicate greater difficulty with reintegration into civilian life.

Time frame:
Through study completion, an average of 6 months following workshop/intervention attendance.
Reported as:
Mean · units on a scale
Military to Civilian Questionnaire (M2C-Q)
units on a scaleACT on LifeEducation, Resources, and Support
Military to Civilian Questionnaire (M2C-Q)2.296 ± 0.0962.395 ± 0.099
SecondaryThe PTSD Checklist for DSM-5 (PCL-5)

The PCL-5 is a 20-item self-report questionnaire to assess post-traumatic stress disorder (PTSD) based on criteria of the Diagnostic and Statistical Manual for Mental Disorders - Version 5 (DSM-5). This scale is available from the National Center for PTSD and is extensively used in Veteran populations. Each item is rated on a 5-point scale with anchors from "not at all" to "extremely" indicating how much the participant has been bothered by the PTSD symptoms in the past month. A total symptom severity score can be obtained by summing the scores for a range of scores from 0 to 80. A higher total score demonstrates more severe PTSD symptoms.

Time frame:
Through study completion, an average of 6 months following workshop/intervention attendance.
Reported as:
Mean · units on a scale
The PTSD Checklist for DSM-5 (PCL-5)
units on a scaleACT on LifeEducation, Resources, and Support
The PTSD Checklist for DSM-5 (PCL-5)42.38 ± 1.9447.36 ± 1.99
SecondaryDefense and Veterans Pain Rating Scale (Pain Severity)

The Defense and Veterans Pain Rating Scale (DVPRS) is a pain assessment tool that assesses severity of pain. It uses a numerical scale ranging from 0 to 10 to assess pain intensity. Minimum Score: 0, representing "No pain". Maximum Score: 10, representing "As bad as pain can be, nothing else matters". It is a reliable and valid instrument developed for use in military populations.

Time frame:
Through study completion, an average of 6 months following workshop/intervention attendance.
Reported as:
Mean · units on a scale
Defense and Veterans Pain Rating Scale (Pain Severity)
units on a scaleACT on LifeEducation, Resources, and Support
Defense and Veterans Pain Rating Scale (Pain Severity)5.77 ± 0.205.87 ± 0.21
Other pre-specifiedAcceptance and Action Questionnaire-II

The Acceptance and Action Questionnaire-II (AAQ-II) is an ACT-specific self-report measure of psychological inflexibility. The AAQ was designed to measure mechanisms hypothesized to be at work in ACT treatments and has been found to mediate behavioral outcomes in ACT interventions. Seven items are rated on a 7-point scale, ranging from 1 ("never true") to 7 ("always true"), with higher scores reflecting greater levels of psychological inflexibility. The total score is calculated by summing the ratings for each of the seven items. The minimum possible score is 7 (7 items x 1 point each).The maximum possible score is 49 (7 items x 7 points each). Higher total scores indicate greater levels of psychological inflexibility and experiential avoidance.

Time frame:
Through study completion, an average of 6 months following workshop/intervention attendance.
Reported as:
Mean · units on a scale
Acceptance and Action Questionnaire-II
units on a scaleACT on LifeEducation, Resources, and Support
Acceptance and Action Questionnaire-II30.10 ± 1.1830.78 ± 1.23
Other pre-specifiedValued Living Questionnaire (VLQ) - Success

Valued Living Questionnaire (VLQ) is a self-report measure that assesses engagement in valued areas of life. Participants first rate the importance of 10 life domains (e.g., family, work, friends etc.) on a 10-point Likert scale (1 = not at all important to 10 = extremely important). They then rate the degree to which their actions over the past week were consistent with each value, from 1 (not at all consistent) to 10 (extremely consistent). The "success" score is the VLQ Composite Score and refers to the composite score that measures how consistently a person is living in accordance with their stated personal values. The Valued Living composite is calculated by multiplying the Importance and Consistency responses for each domain and then calculating the mean of those scores. The resulting Valued Living Composite scores can range from 10-100. A higher score indicates greater alignment between actions and values, which is associated with positive psychological outcomes.

Time frame:
Through study completion, an average of 6 months following workshop/intervention attendance.
Reported as:
Mean · units on a scale
Valued Living Questionnaire (VLQ) - Success
units on a scaleACT on LifeEducation, Resources, and Support
Valued Living Questionnaire (VLQ) - Success48.80 ± 2.3851.54 ± 2.41
Other pre-specifiedSelf-reported Service Utilization (Emotional Problems)

The outcome measure is either Yes or No and then we computed the percentage of study participants that responded 'yes' on having utilized services for emotional problems from any of the following, medical provider, spiritual provider(priest/minister), psychiatric help or had hospital admission(in or outpatient) or ER admission.

Time frame:
Through study completion, an average of 6 months following workshop/intervention attendance.
Reported as:
Count of participants · Participants
Self-reported Service Utilization (Emotional Problems)
ParticipantsACT on LifeEducation, Resources, and Support
Self-reported Service Utilization (Emotional Problems)5444

Adverse events

Collected over Through study completion, up to 6 months following workshop attendance.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
ACT on Life0/90 (0%)0/90 (0%)2/90 (2.2%)
Education, Resources, and Support0/86 (0%)0/86 (0%)2/86 (2.3%)
Most frequent other events
Most frequent other events
EventACT on LifeEducation, Resources, and Support
Suicidal IdeationPsychiatric disorders2/902/86

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)ACT on LifeEducation, Resources, and SupportTotal
<=18 years000
Between 18 and 65 years9086176
>=65 years000
Age, Continuous
Age, Continuous(years)ACT on LifeEducation, Resources, and SupportTotal
Mean40.6 ± 7.840.7 ± 7.740.6 ± 7.7
Sex: Female, Male
Sex: Female, Male(Participants)ACT on LifeEducation, Resources, and SupportTotal
Female131326
Male7773150
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)ACT on LifeEducation, Resources, and SupportTotal
Hispanic or Latino192443
Not Hispanic or Latino6555120
Unknown or Not Reported6713
Race (NIH/OMB)
Race (NIH/OMB)(Participants)ACT on LifeEducation, Resources, and SupportTotal
American Indian or Alaska Native000
Asian202
Native Hawaiian or Other Pacific Islander011
Black or African American282553
White373067
More than one race268
Unknown or Not Reported212445
Region of Enrollment
Region of Enrollment(Participants)ACT on LifeEducation, Resources, and SupportTotal
United States9086176
Depression, Anxiety, and Stress Symptoms (DASS-21) -TOTAL Score
Depression, Anxiety, and Stress Symptoms (DASS-21) -TOTAL Score(units on a scale)ACT on LifeEducation, Resources, and SupportTotal
Mean33.6 ± 10.534.9 ± 12.034.3 ± 11.3
Military to Civilian Questionnaire (M2C-Q)
Military to Civilian Questionnaire (M2C-Q)(units on a scale)ACT on LifeEducation, Resources, and SupportTotal
Mean2.55 ± 0.622.53 ± 0.782.54 ± 0.70

4 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Michael E. DeBakey VA Medical Center, Houston, TX
    Houston, Texas 77030-4211, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04143243
Responsible party
Sponsor
First posted
Oct 29, 2019
Start date
Jul 1, 2020
Primary completion
Aug 3, 2024
Completion
Aug 3, 2024
Results posted
Oct 8, 2025
Last update
Oct 8, 2025

Study contacts

Lilian N. Dindo, PhD
principal investigator · Michael E. DeBakey VA Medical Center, Houston, TX

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion